The DOI matches its Crossref record; 259 of the 259 references it cites were found in a registry or an index.
Scedosporium and Lomentospora: an updated overview of underrated opportunists
Open accessAbstract
Species of Scedosporium and Lomentospora are considered as emerging opportunists, affecting immunosuppressed and otherwise debilitated patients, although classically they are known from causing trauma-associated infections in healthy individuals. Clinical manifestations range from local infection to pulmonary colonization and severe invasive disease, in which mortality rates may be over 80%. These unacceptably high rates are due to the clinical status of patients, diagnostic difficulties, and to intrinsic antifungal resistance of these fungi. In consequence, several consortia have been founded to increase research efforts on these orphan fungi. The current review presents recent findings and summarizes the most relevant points, including the Scedosporium/Lomentospora taxonomy, environmental distribution, epidemiology, pathology, virulence factors, immunology, diagnostic methods, and therapeutic strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Scedosporium and Lomentospora species are rare opportunistic molds demonstrating broad and even pan-resistant tendencies with mortality rates breaching 80%.”
From Investigational Agents for the Treatment of Resistant Yeasts and Molds (2021) · cites this paper as [14]
In the citing paper
“Currently, infections by these organisms have few, if any, reliable therapeutic options.”
From Investigational Agents for the Treatment of Resistant Yeasts and Molds (2021) · cites this paper as [14]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hidden Killers: Human Fungal Infections
Brown, G. D., Denning, D. W., Gow, N. A. R., Levitz, S. M., Netea, M. G., & White, T. C. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004404 · Cited by 4,284
Romani, L. (2011) · Nature Reviews Immunology · doi:10.1038/nri2939 · Cited by 1,793
Pappas, P. G., Alexander, B. D., Andes, D. R., Hadley, S., Kauffman, C. A., Freifeld, A., Anaissie, E. J., Brumble, L. M., Herwaldt, L., Ito, J., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/651262 · Cited by 1,570
International Code of Nomenclature for algae, fungi, and plants (Melbourne Code)
McNeill, J. R., Barrie, F. R., Buck, W., et al. (2012) · Cited by 1,138
An integrated model of the recognition of Candida albicans by the innate immune system
Netea, M. G., Brown, G. D., Kullberg, B. J., & Gow, N. A. R. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1815 · Cited by 946
The antifungal pipeline: a reality check
Perfect, J. R. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.46 · Cited by 866
Infections Caused by Scedosporium spp
Cortez, K. J., Roilides, E., Quiroz-Telles, F., Meletiadis, J., Antachopoulos, C., Knudsen, T., Buchanan, W., Milanovich, J., Sutton, D. A., Fothergill, A., et al. (2008) · Clinical Microbiology Reviews · doi:10.1128/cmr.00039-07 · Cited by 786
Verweij, P. E., Chowdhary, A., Melchers, W. J. G., & Meis, J. F. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ885 · Cited by 561
Taurine and Inflammatory Diseases
Marcinkiewicz, J., & Kontny, E. (2014) · Amino Acids · doi:10.1007/s00726-012-1361-4 · Cited by 531
Changing epidemiology of systemic fungal infections
Richardson, M., & Lass-Flörl, C. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2008.01978.x · Cited by 524
Research works printed but not linked: 3
- Rodriguez-Tudela, 2009, Epidemiology and outcome of Scedosporium prolificans infection, a review of 162 cases, Med Mycol, 47, 359, 10.1080/13693780802524506 · DOI
- Sedlacek, 2015, Prevalence of Scedosporium species and Lomentospora prolificans in patients with cystic fibrosis in a multicenter trial by use of a selective medium, J Cyst Fibros, 14, 237, 10.1016/j.jcf.2014.12.014 · DOI
- Nagl, 2013, Tolerability of inhaled N-chlorotaurine versus sodium chloride in the mouse, J Med Res Pract, 2, 163
Cited by
Sorted by citations
Investigational Agents for the Treatment of Resistant Yeasts and Molds
Seiler, G. T., & Ostrosky-Zeichner, L. (2021) · Current Fungal Infection Reports · doi:10.1007/s12281-021-00419-5 · Cited by 32
Metadata
- Authors
- Ramirez-Garcia, A., Pellon, A., Rementeria, A., Buldain, I., Barreto-Bergter, E., Rollin-Pinheiro, R., de Meirelles, J. V., Xisto, M. I. D. S., Ranque, S., Havlicek, V., Vandeputte, P., Govic, Y. L., Bouchara, J.-P., Giraud, S., Chen, S., Rainer, J., Alastruey-Izquierdo, A., Martin-Gomez, M. T., López-Soria, L. M., Peman, J., Schwarz, C., Bernhardt, A., Tintelnot, K., Capilla, J., Martin-Vicente, A., Cano-Lira, J., Nagl, M., Lackner, M., Irinyi, L., Meyer, W., de Hoog, S., & Hernando, F. L.
- Affiliations
- Fungal and Bacterial Biomics Research Group, Department of Immunology, Microbiology and Parasitology, Faculty of Science and Technology, University of the Basque Country (UPV/EHU), Leioa, Spain
- University of the Basque Country (ES)
- Instituto de Microbiologia, UFRJ, Rio de Janeiro, RJ, Brazil
- Laboratoire de Parasitologie-Mycologie, AP-HM / CHU Timone, Marseille, France
- Institute of Microbiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic
- Centre Hospitalier Universitaire d'Angers (FR)
- Université d'Angers (FR)
- Centre for Infectious Diseases and Microbiology Laboratory Services, ICPMR, Westmead Hospital, The University of Sydney, New South Wales, Australia
- Universität Innsbruck (AT)
- Mycology Reference Laboratory, National Centre for Microbiology. Instituto de Salud Carlos III. Majadahonda, Madrid, Spain
- Microbiology Department. Hospital Universitari Vall d’Hebron, Barcelona, Spain
- Microbiology Department. Hospital Universitario Cruces, Barakaldo, Spain
- Microbiology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain
- Charité – Universitätsmedizin Berlin (DE)
- Robert Koch Institute (DE)
- Institut de Recerca Biomèdica Catalunya Sud (ES)
- Mycology Unit, Medical School and IISPV, Universitat Rovira i Virgili, Reus, Spain
- Innsbruck Medical University (AT)
- Molecular Mycology Research Laboratory, Centre for Infectious Diseases and Microbiology, Westmead Clinical School, Sydney Medical School – Westmead Hospital, Marie Bashir Institute for Infectious Diseases and Biosecurity, The University of Sydney, Westmead Institute for Medical Research, Sydney, New South Wales, Australia
- The University of Sydney (AU)
- Westerdijk Fungal Biodiversity Institute, Utrecht, The Netherlands
- ORCID
- Venue
- Medical Mycology
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-03-10
- Volume
- 56
- Issue
- suppl_1
- Pages
- S102-S125
- ISSN
- 0268-1218 (ISSN-L)
- 1369-3786
- 1460-2709
- OpenAlex
- W2789742163
- Cited by
- 264
- References
- 259
- Citations by year
- 2026: 21 · 2025: 27 · 2024: 33 · 2023: 41 · 2022: 33 · 2021: 48 · 2020: 26 · 2019: 23 · 2018: 9
- FWCI
- 2.44
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Medical Mycology (publishedVersion)
- PubMed (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- HAL (submittedVersion, other-oa)
- Communities in ADDI (University of the Basque Country) (submittedVersion, other-oa)
- Hispana (submittedVersion, other-oa)
- KNAW Research Portal (The Royal Netherlands Academy of Arts and Sciences) (submittedVersion)
- Funders
- Czech Science Foundation (16-20229S)
- National Health and Medical Research Council of Australia (APP1031952, APP1121936)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Health Sciences › Medicine › Microbiology (medical) › Actinomycetales infections and treatment
- Keywords
- Scedosporium, opportunistic fungal infection, emerging fungal pathogens, immunocompromised patients, invasive fungal infections, antifungal resistance, fungal taxonomy, virulence factors, fungal immunology, fungal infection diagnosis, antifungal therapy, environmental distribution, lung colonization
- MeSH terms
- Antifungal Agents, Ascomycota, Combined Modality Therapy, Ecology, Humans, Mycoses, Opportunistic Infections, Surgical Procedures, Operative, Immunocompromised Host, Scedosporium, Drug Resistance, Multiple, Fungal, Virulence Factors, Host-Pathogen Interactions, Molecular Typing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
